JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 févr. 2026, 00:00 UTC

Actions en Tendance

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 févr. 2026, 22:55 UTC

Résultats

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 févr. 2026, 21:44 UTC

Résultats

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 févr. 2026, 21:39 UTC

Résultats

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 févr. 2026, 00:00 UTC

Résultats

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 févr. 2026, 00:00 UTC

Résultats

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 févr. 2026, 23:45 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 févr. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 févr. 2026, 22:59 UTC

Acquisitions, Fusions, Rachats

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 févr. 2026, 22:30 UTC

Résultats

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 févr. 2026, 22:30 UTC

Résultats

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 févr. 2026, 22:21 UTC

Résultats

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 févr. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 févr. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 févr. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4 févr. 2026, 21:53 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 févr. 2026, 21:51 UTC

Résultats

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 févr. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 févr. 2026, 21:45 UTC

Résultats

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 févr. 2026, 21:44 UTC

Résultats

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 févr. 2026, 21:43 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 févr. 2026, 21:41 UTC

Résultats

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 févr. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 févr. 2026, 21:30 UTC

Résultats

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 févr. 2026, 21:30 UTC

Résultats

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 févr. 2026, 21:30 UTC

Résultats

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat